246 related articles for article (PubMed ID: 20828387)
1. Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol.
Mishra PK; Tyagi N; Sen U; Joshua IG; Tyagi SC
Cardiovasc Diabetol; 2010 Sep; 9():49. PubMed ID: 20828387
[TBL] [Abstract][Full Text] [Related]
2. Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance.
Sen U; Rodriguez WE; Tyagi N; Kumar M; Kundu S; Tyagi SC
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1205-12. PubMed ID: 18780770
[TBL] [Abstract][Full Text] [Related]
3. Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone.
Henderson BC; Sen U; Reynolds C; Moshal KS; Ovechkin A; Tyagi N; Kartha GK; Rodriguez WE; Tyagi SC
Int J Biol Sci; 2007 Sep; 3(6):385-92. PubMed ID: 17848984
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine-dependent cardiac remodeling and endothelial-myocyte coupling in a 2 kidney, 1 clip Goldblatt hypertension mouse model.
Tyagi N; Moshal KS; Lominadze D; Ovechkin AV; Tyagi SC
Can J Physiol Pharmacol; 2005 Jul; 83(7):583-94. PubMed ID: 16091784
[TBL] [Abstract][Full Text] [Related]
5. PPAR gamma agonist normalizes glomerular filtration rate, tissue levels of homocysteine, and attenuates endothelial-myocyte uncoupling in alloxan induced diabetic mice.
Rodriguez WE; Sen U; Tyagi N; Kumar M; Carneal G; Aggrawal D; Newsome J; Tyagi SC
Int J Biol Sci; 2008 Aug; 4(4):236-44. PubMed ID: 18690293
[TBL] [Abstract][Full Text] [Related]
6. 3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice.
Ovechkin AV; Tyagi N; Sen U; Lominadze D; Steed MM; Moshal KS; Tyagi SC
Am J Physiol Lung Cell Mol Physiol; 2006 Nov; 291(5):L905-11. PubMed ID: 16815886
[TBL] [Abstract][Full Text] [Related]
7. Ciglitazone ameliorates homocysteine-mediated mitochondrial translocation and matrix metalloproteinase-9 activation in endothelial cells by inducing peroxisome proliferator activated receptor-gamma activity.
Tyagi N; Moshal KS; Sen U; Lominadze D; Ovechkin AV; Tyagi SC
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(5):21-7. PubMed ID: 17543202
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure.
Sen U; Basu P; Abe OA; Givvimani S; Tyagi N; Metreveli N; Shah KS; Passmore JC; Tyagi SC
Am J Physiol Renal Physiol; 2009 Aug; 297(2):F410-9. PubMed ID: 19474193
[TBL] [Abstract][Full Text] [Related]
9. Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway.
Tyagi N; Gillespie W; Vacek JC; Sen U; Tyagi SC; Lominadze D
J Cell Physiol; 2009 Jul; 220(1):257-66. PubMed ID: 19308943
[TBL] [Abstract][Full Text] [Related]
10. Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia.
Tyagi N; Qipshidze N; Sen U; Rodriguez W; Ovechkin A; Tyagi SC
Int J Physiol Pathophysiol Pharmacol; 2011 Sep; 3(3):210-22. PubMed ID: 21941612
[TBL] [Abstract][Full Text] [Related]
11. Cardiac synchronous and dys-synchronous remodeling in diabetes mellitus.
Sen U; Tyagi N; Moshal KS; Kartha GK; Rosenberger D; Henderson BC; Joshua IG; Tyagi SC
Antioxid Redox Signal; 2007 Jul; 9(7):971-8. PubMed ID: 17508918
[TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinemic diabetic cardiomyopathy: oxidative stress, remodeling, and endothelial-myocyte uncoupling.
Tyagi SC; Rodriguez W; Patel AM; Roberts AM; Falcone JC; Passmore JC; Fleming JT; Joshua IG
J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):1-10. PubMed ID: 15821833
[TBL] [Abstract][Full Text] [Related]
13. Exogenous Hydrogen Sulfide Attenuates Cardiac Fibrosis Through Reactive Oxygen Species Signal Pathways in Experimental Diabetes Mellitus Models.
Zheng D; Dong S; Li T; Yang F; Yu X; Wu J; Zhong X; Zhao Y; Wang L; Xu C; Lu F; Zhang W
Cell Physiol Biochem; 2015; 36(3):917-29. PubMed ID: 26088607
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of beta2-adrenergic receptors and homocysteine metabolic enzymes cause diabetic cardiomyopathy.
Mishra PK; Givvimani S; Metreveli N; Tyagi SC
Biochem Biophys Res Commun; 2010 Oct; 401(2):175-81. PubMed ID: 20836991
[TBL] [Abstract][Full Text] [Related]
15. Nitrotyrosinylation, remodeling and endothelial-myocyte uncoupling in iNOS, cystathionine beta synthase (CBS) knockouts and iNOS/CBS double knockout mice.
Kundu S; Kumar M; Sen U; Mishra PK; Tyagi N; Metreveli N; Lominadze D; Rodriguez W; Tyagi SC
J Cell Biochem; 2009 Jan; 106(1):119-26. PubMed ID: 19021146
[TBL] [Abstract][Full Text] [Related]
16. The effects of PPAR-γ agonist pioglitazone on renal ischemia/reperfusion injury in rats.
Reel B; Guzeloglu M; Bagriyanik A; Atmaca S; Aykut K; Albayrak G; Hazan E
J Surg Res; 2013 Jun; 182(1):176-84. PubMed ID: 22981741
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of cardiovascular remodeling in hyperhomocysteinemia.
Steed MM; Tyagi SC
Antioxid Redox Signal; 2011 Oct; 15(7):1927-43. PubMed ID: 21126196
[TBL] [Abstract][Full Text] [Related]
18. Tempol ameliorates cardiac fibrosis in streptozotocin-induced diabetic rats: role of oxidative stress in diabetic cardiomyopathy.
Taye A; Abouzied MM; Mohafez OM
Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1071-80. PubMed ID: 23949118
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs are involved in homocysteine-induced cardiac remodeling.
Mishra PK; Tyagi N; Kundu S; Tyagi SC
Cell Biochem Biophys; 2009; 55(3):153-62. PubMed ID: 19669742
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone prevents cardiac remodeling in high-fat, high-calorie-induced Type 2 diabetes mellitus.
Rodriguez WE; Joshua IG; Falcone JC; Tyagi SC
Am J Physiol Heart Circ Physiol; 2006 Jul; 291(1):H81-7. PubMed ID: 16489101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
